| H3P19 |
|
H3 histone pseudogene 19
|
|
|
0.631 |
0.577 |
| LOC105379528 |
|
uncharacterized LOC105379528
|
|
|
0.617 |
0.615 |
| LOC390714 |
|
immunoglobulin heavy chain variable region
|
|
|
0.617 |
0.615 |
| TRG |
|
T cell receptor gamma locus
|
|
|
0.631 |
0.538 |
| ALL1 |
|
Leukemia, acute lymphocytic, susceptibility to, 1
|
|
|
0.636 |
0.269 |
| RAB4B-EGLN2 |
|
RAB4B-EGLN2 readthrough (NMD candidate)
|
|
|
0.641 |
0.654 |
| TARP |
|
TCR gamma alternate reading frame protein
|
|
|
0.638 |
0.500 |
| H3P5 |
|
H3 histone pseudogene 5
|
|
|
0.656 |
0.538 |
| H3P44 |
|
H3 histone pseudogene 44
|
|
|
0.636 |
0.462 |
| TRAJ60 |
|
T cell receptor alpha joining 60 (pseudogene)
|
|
|
0.751 |
0.346 |
| JPX |
|
JPX transcript, XIST activator
|
|
|
0.769 |
0.308 |
| MIR1193 |
|
microRNA 1193
|
|
|
0.780 |
0.192 |
| TCL6 |
|
T cell leukemia/lymphoma 6
|
|
|
0.821 |
0.462 |
| TCL4 |
|
T cell leukemia/lymphoma 4
|
|
|
1.000 |
0.115 |
| TRBV16 |
A0A087WV62
|
T cell receptor beta variable 16 (gene/pseudogene)
|
|
|
0.695 |
0.500 |
| TRBC2 |
A0A5B9
|
T cell receptor beta constant 2
|
|
|
0.931 |
0.192 |
| POTEF |
A5A3E0
|
POTE ankyrin domain family member F
|
|
5.5E-06 |
0.481 |
0.885 |
| LGALS9 |
O00182
|
galectin 9
|
Signaling
|
6.5E-06 |
0.496 |
0.769 |
| PSMD12 |
O00232
|
proteasome 26S subunit, non-ATPase 12
|
Enzyme modulator
|
1.00 |
0.578 |
0.808 |
| PIK3CD |
O00329
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
Kinase
|
1.00 |
0.319 |
0.885 |
| DLL1 |
O00548
|
delta like canonical Notch ligand 1
|
|
1.00 |
0.492 |
0.808 |
| CXCR6 |
O00574
|
C-X-C motif chemokine receptor 6
|
G-protein coupled receptor
|
5.7E-05 |
0.448 |
0.885 |
| CCL22 |
O00626
|
C-C motif chemokine ligand 22
|
Signaling
|
8.4E-03 |
0.500 |
0.846 |
| MAP2K7 |
O14733
|
mitogen-activated protein kinase kinase 7
|
Kinase
|
1.00 |
0.419 |
0.808 |
| PRMT5 |
O14744
|
protein arginine methyltransferase 5
|
Epigenetic regulator
|
1.00 |
0.539 |
0.769 |